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The Src kinase family comprises nine homologous members whose
distinct expression patterns and cellular distributions indicate that
they have unique roles. These roles have not been determined
because genetic manipulation has not produced clearly distinct
phenotypes, and the kinases’ homology complicates generation of
specific inhibitors. Through insertion of a modified FK506 binding
protein (insertable FKBP12, iFKBP) into the protein kinase isoforms
Fyn, Src, Lyn, and Yes, we engineered kinase analogs that can be
activated within minutes in living cells (RapR analogs). Combining
our RapR analogs with computational tools for quantifying and
characterizing cellular dynamics, we demonstrate that Src family
isoforms produce very different phenotypes, encompassing cell
spreading, polarized motility, and production of long, thin cell
extensions. Activation of Src and Fyn led to patterns of kinase
translocation that correlated with morphological changes in tem-
porally distinct stages. Phenotypes were dependent on N-terminal
acylation, not on Src homology 3 (SH3) and Src homology 2 (SH2)
domains, and correlated with movement between a perinuclear
compartment, adhesions, and the plasma membrane.
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Since its discovery, c-Src (1) has been subject to intensive re-search into its cellular functions and regulation. Whereas
c-Src is the best-studied protooncogene, less is known about the
other, closely related Src family kinase (SFK) members. Their
high degree of similarity in structure and regulation suggests that
SFKs can partially compensate for each other in vivo. Indeed,
knockout studies have shown that only mice deficient in all three
genes (src, yes, and fyn) show embryonic lethality (2). Early
studies demonstrated that disruption of Src or Fyn genes in-
dividually resulted only in subtle changes in function of a few cell
types (e.g., osteoclasts for src−/−, and T cells for fyn−/−) (3, 4).
Roche et al. provided strong evidence that Src, Yes, and Fyn
substitute for each other during cell cycle progression (5). These
studies suggested that there is a high degree of functional re-
dundancy among Src family kinases.
Nonetheless, emerging evidence indicates that Src and Fyn
regulate distinct processes in the same cell. Down-regulation of
Fyn expression enhances VEGF-stimulated migration of endo-
thelial cells, whereas down-regulation of Src does not (6). Dif-
ferences in the transforming capacity of SFKs are thought to
depend on their affinity for cholesterol-enriched membrane
microdomains, which is determined in part by their N-terminal
lipid modifications (7, 8). Src has higher tumorigenic potential
than Fyn in prostate epithelium, and this is differently affected
by alterations in N-terminal palmitoylation (9). Previous studies
have shown that Src localizes to perinuclear endosomal com-
partments and translocates to the plasma membrane upon acti-
vation (10–12), whereas Fyn localizes to the plasma membrane
regardless of its activity (13, 14). Although these studies suggest
that localization is important in differentiating the actions of the
two kinases, they do not identify specific roles associated with
particular subcellular locations.
Various techniques have been applied to elucidate the differ-
ences in signaling specificity of SFKs. Kinase–substrate interactions
have been examined using purified substrates (15). Mutated ki-
nases with selectivity for radiolabeled ATP analogs have identified
directly phosphorylated substrates of Src (16). These methods were
restricted to cell lysates or purified proteins, and so were unable to
address the role of cellular localization in substrate specificity.
To dissect the unique role of different SFK isoforms (2–4, 17, 18)
in living cells, we engineered regulatable analogs of Fyn, Yes, and
LynA kinases using our rapamycin-regulated activation (RapR)
strategy, which has been developed using Src as a prototype
(19, 20). Insertable FKBP12 (iFKBP, a truncated form of FKBP)
was inserted into the catalytic domain of each SFK, which abolished
their kinase activity. Activity was rescued by treating cells with
rapamycin in the presence of the FKBP12-rapamycin binding
domain (FRB) (Fig. 1A). Molecular dynamics studies have in-
dicated that heterodimerization of the inserted iFKBP with FRB
likely reduces the conformational mobility of the kinase G loop,
restoring ATP binding (3, 21).
These analogs enabled activation of each isoform specifically,
within minutes, resulting in clear phenotypic differences. Unlike
genetic modifications of cell populations, there was little time for
the cell to compensate for kinase activation before observation.
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The induced cell behaviors occurred in a succession of stages,
associated with changes in the subcellular distribution of each
kinase. We focused on Src and Fyn, developing quantitative tools
to carefully characterize the kinetics of induced behaviors and
associated localization dynamics. Our results indicated that Src’s
unique ability to induce polarized movement shortly after kinase
activation results from its localization in a perinuclear com-
partment, where it phosphorylates substrates that traffic on
microtubules to the cell perimeter. Both the localization dy-
namics and phenotype differences between Src and Fyn were
dependent on N-terminal lipid modifications, and not on SH2
and SH3 domain interactions.
Results
Based on the structural similarity of the catalytic domains in the
SFKs (3, 21), we first identified the appropriate site for insertion
of iFKBP into Fyn, Yes, and LynA. The insertion site could be
identified simply through sequence analysis: iFKBP was inserted
in a sequence linking the kinase G loop with a β-sheet in the
catalytic domain (Fig. 1B). A constitutively activating mutation
was included so that kinase activity would be solely under the
control of rapamycin. To optimize the regulation of kinase ac-
tivity, we tested various linkers connecting iFKBP to the catalytic
domain of Fyn, using in vitro kinase assays. Whereas the shorter
linkers gave similar results, the longest linker (GS3PG–GPG)
showed the weakest restoration of catalytic activity, suggesting
that the longer linker could not propagate conformational
changes to the G loop. Formation of the kinase–FRB complex, and
resultant kinase activation, occurred only in the presence of
rapamycin (Fig. S1A). Based on this optimization of the iFKBP
insertion, we generated RapR Yes and RapR LynA using a short
linker (GPG–GPG) to fuse iFKBP into the kinase catalytic
domains (Fig. S1 B and C). Each of these RapR kinases showed
restored activity upon treatment with rapamycin. Importantly,
upon addition of rapamycin, catalytically inactive (kinase dead)
mutants of the RapR kinases formed complexes with FRB but
showed no change in activity, indicating that kinase activity was
induced by rapamycin treatment (Fig. S1). RapR Fyn produced
normal levels of phosphorylation for endogenous p130 Crk-
associated substrate (p130Cas), focal adhesion kinase (FAK),
cortactin, and paxillin (Fig. S2). Published characterization of
RapR Src and its analogs indicated that it has normal kinetics,
localization, and levels of kinase activity (19, 22, 23).
Because the RapR kinases enabled rapid and specific activation
of each SFK, they could be used to examine the immediate effects
of individual Src family members on cell behavior. Each RapR
kinase was coexpressed with FRB in COS-7 cells and activated by
adding rapamycin. Fig. 2A and Movies S1–S4 show the clearly
distinct morphological changes produced by each isoform. Acti-
vation of Fyn generated uniform spreading, whereas activation of
Src initiated polarized movement. LynA, which is mainly expressed
in hematopoietic cells (24), induced long membrane projections
with complex shapes, including sharp bends. Activation of Yes
induced a phenotype intermediate between that of Src and Fyn.
We decided to focus on Fyn and Src because of their strongly
contrasting phenotypes and their well-documented role in me-
tastasis (25–27). To objectively analyze complex changes in cell
morphology induced by each kinase required unbiased compu-
tational tools that could capture and quantify key features of
cellular motion. To this end, we developed versatile methods for
analyzing changes in cell shape and position. Our approach not
only provides rigor in the comparison of experimental observa-
tions, but also enables the extraction of information that is not
readily apparent by visual inspection. Here we provide a brief
description of our methods: To characterize polarized movement,
the inward or outward displacement of the cell edge was de-
termined for each pair of successive time frames at points equally
spaced along the edge. The displacements were mapped onto
a circle and the degree of polarization in the displacement dis-
tribution was computed, enabling us to quantify consistently the
polarized movement of cells with arbitrary geometry (Fig. 2B). As
a second measure of shape changes, we calculated the change in
cell area between successive time frames. An informative way to
visualize these two parameters (polarization and rate of area
change) is to plot them as points in 2D parameter space. In this
way the data form a trajectory that shows the changing behavior of
the cell over time (Fig. 2 B and C and Movie S5). Dividing the
parameter space into distinct regions allowed us to classify cell
shape changes for each time point as one of five different types of
motion: uniform spreading, polarized spreading, polarized move-
ment, polarized shrinkage, and uniform shrinkage. We used this
method to compare cells in which either Fyn or Src had been
activated. The plot in Fig. 2D (from 57 Fyn cells and 55 Src cells)
shows the distributions for the five different cellular behaviors
across the populations and how these distributions changed over
time. Both Fyn and Src initially produced extensive spreading, but
only for Src was this followed by polarized movement (see also
Fig. S3 and Table S1). We were concerned that the differences
between Fyn and Src might be due to differences in expression
level, so we compared kinase expression in the flat COS-7 cells by
determining the brightness per unit area of EGFP-tagged RapR
kinases. Comparing high versus low expressers (Fig. S4) showed
that expression level did not affect our conclusions. These studies
quantified clear differences in the morphodynamic cell behaviors
induced by Fyn versus Src.
We next sought to identify which structural features of Fyn and
Src were responsible for their induction of different phenotypes.
The SH3 and SH2 domains of SFKs have been identified as ef-
fector binding sites and were proposed to mediate signaling speci-
ficity (28–31). Surprisingly, switching the effector binding domains
of Src and Fyn had little effect on the cellular responses described
above (Fig. S5 A–C). There were, however, striking differences in
the initial localization and localization dynamics of Fyn and Src.
RapR kinases were labeled with EGFP to visualize their localiza-
tion during activation (Movies S6 and S7), and kinetics of locali-
zation changes were quantified as shown in Fig. 3 A and B. Before
activation, wild-type Src was concentrated on one side of the nu-
cleus, where it has been shown to be associated with the Golgi
apparatus and vesicular compartments (12, 14, 32). In contrast,


















Fig. 1. Design of RapR kinases. (A) Schematic representation of the ap-
proach used to regulate catalytic activity of SFKs. The insertion of iFKBP at
a highly conserved site in the catalytic domain of each kinase resulted in loss
of kinase activity. Catalytic activity was restored by rapamycin, which in-
duced binding of iFKBP and coexpressed FRB. (B) Sequence alignment of
SFKs shows that there is a well-defined loop where iFKBP is inserted (blue). It
is linked to the G loop (red) through a β-sheet in each SFK.
























wild-type Fyn showed uniform distribution in the plasma membrane
(with some concentration in membrane patches and puncta, but no
perinuclear accumulation) (Fig. 3C and Fig. S6). After addition of
rapamycin, Src moved away from the perinuclear region as polar-
ized movement began. Fyn remained uniformly distributed upon
activation (Fig. 3B). Analyzing the kinetics of localization dynamics
showed that Src’s induction of polarized motility coincided with its
departure from the perinuclear compartment (Figs. 2D and 3B).
Swapping the SH3-SH2 domains of Src and Fyn did not affect their
localization or translocation upon activation (Fig. S5D).
We examined acylation of Fyn and Src (Fig. 3A) because ac-
ylation is an important determinant of kinase distribution (8, 13,
33, 34). Both Fyn and Src are cotranslationally myristoylated at
an N-terminal glycine, but only Fyn is palmitoylated, at cysteines
3 and 6 (33, 35). We used previously described mutations of the
SH4 domain to alter the lipidation of the two proteins (14, 33)
(Fig. 3A): In Fyn, Cys3 and Cys6 were substituted for serines to
eliminate the addition of palmitoyl groups (Fyn Palm−), ren-
dering the acylation of Fyn like that of Src (33). To render the
acylation of Src like that of Fyn, serines 3 and 6 were substituted
with cysteines, generating the Fyn acylation pattern (Src Palm+).
Remarkably, removal of the palmitoylation sites from Fyn
(Fyn Palm−) resulted in conversion to the Src phenotype (Figs.
3B and 4 A and B, Left), producing kinase accumulation at the
perinuclear region before activation, kinase dispersion upon
activation, and induction of polarized movement. In contrast,
introducing cysteine into Src (Src Palm+) did not produce clear
conversion to a Fyn phenotype (Fig. 4B, Right). Src Palm+ con-
tinued to show perinuclear localization before activation, and
dispersion upon activation (Fig. 3B). Cells did show a reduction
in the persistence of polarized movement produced by wild-type
Src (Fig. S7C). Conversion of Fyn localization and trafficking
patterns to those of Src were accompanied by conversion to the
Src motility phenotype. This strongly suggests that perinuclear
localization and translocation from the perinuclear region is
important to Src’s unique ability to induce polarized movement
(Fig. 3B). Simply adding palmitoylatable cysteines to Src was not
sufficient to produce Fyn phenotypes or trafficking patterns. This
could be because palmitoylation was incomplete [as previously
observed (33)], or because Src possesses additional sequences
that are involved in anchoring at the perinuclear region.
Signaling messengers travel along microtubules to specific
regions of the cell edge to produce polarization (36–39), so
we examined whether microtubules (MT) are required for Src-
induced polarized movement. Cells were treated with the
MT polymerization inhibitor nocodazole before addition of
rapamycin. Upon kinase activation, nocodazole-treated cells
protruded randomly rather than undergoing directed motility
(Fig. 5A and Movie S8), consistent with a role for MT in regu-
lation of cell polarization (39). Interestingly, Src release from
the perinuclear compartment occurred despite MT disruption,
indicating that release was under the control of a mechanism
independent of trafficking on MT, consistent with previous
studies (10).
We examined the role of Src’s Unique domain, a non-
conserved region within SFKs that is thought to mediate SFK–
lipid interactions (40, 41). Replacing the Unique domain of Src
with that of Fyn [Src(FynSH4U)] reduced but did not fully ab-
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Fig. 2. Distinct morphological changes resulted from activating different SFK
isoforms. (A) Morphological changes induced by activating different SFKs in
COS-7 cells. (B) Automated cell analysis used toquantifymorphological changes.
(Upper Left) The gray area shows a cell at time t. Red and blue line segments
show relative cell motion in the time interval T (outward motion red, inward
motion blue). (Upper Right) The displacement of points equally spaced around
the cell edge was mapped onto a circle to assess polarization. (Lower) A
parameter space formed by the rate of area change and polarization is used
to characterize boundary motion over time, with different regions of the
parameter space corresponding to characteristic types of cell motion. (C) The
morphodynamics of each cell was represented as a trajectory in parameter
space. (Lower) Shape changes between two time points (early red, later
blue) for a specific cell; (Upper) These transitions are noted. (D) The timing of
specific morphological changes analyzed in populations of RapR Fyn versus
RapR Src cells using this quantitative method. P. Mv, polarized movement;
P. Shr, polarized shrinkage; P. Spr, polarized spreading; U. Shr, uniform
shrinkage; U. Spr, uniform spreading.
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Src–Fyn chimera again dispersed, leading to clear but delayed
polarized movement (Figs. 3 and 4C).
SFKs are known to mediate adhesion signaling in motility
(42, 43), and both Fyn and Src affected focal adhesions upon
activation (Movies S9 and S10). Because adhesion changes
were too complex to characterize by eye, we turned to our re-
cently published methods for quantitative analysis of adhesion
dynamics (44). Both Src and Fyn increased adhesion turnover,
but Src had a stronger effect. Accumulation at adhesions was
seen for RapR Src but not RapR Fyn. The removal of Fyn’s
palmitoyl groups (Fyn Palm−), which had caused it to duplicate
Src’s trafficking patterns, also increased its accumulation at
adhesions (Figs. 3B and 5B). Src’s induction of disassembly may
be important to its induction of polarized motility, as trans-
locating cells must detach their trailing edges.
Discussion
RapR analogs provided rapid activation of specific SFK isoforms
in living cells, revealing distinct phenotypes induced by Fyn, Src,
Yes, and Lyn. Striking differences indicated a unique role for
each isoform in the control of morphodynamics. To quantify and
characterize the role of each isoform in regulating cellular dy-
namics, we developed a suite of computational tools that could
analyze the distribution of behaviors across cell populations.
These tools revealed that Fyn and Src initially generated sym-
metric spreading, but only Src produced polarized cell movement
at later times. The different phenotypes induced by Src and Fyn
were associated with distinct trafficking patterns: Src produced
polarized spreading only after it was released from a perinuclear
compartment, when it moved to the plasma membrane and focal
adhesions, inducing increased adhesion turnover. Fyn was dis-
tributed more uniformly both before and after activation, and
generated uniform cell spreading. Effects of nocodazole were
consistent with a role for MT-mediated trafficking in producing
polarization, but MTs were not required for Src release from the
perinuclear compartment. Trafficking and phenotypes were
strongly dependent on N-terminal acylation, but not on the
kinases’ SH2 and SH3 interaction domains.
Both Src and Fyn initially triggered uniform, symmetric cell
spreading. However, after this initial stage, only Src produced
predominantly polarization and motility. These differences were
not dictated by the SH3 or SH2 domains that play important
roles in Src and Fyn’s substrate binding and subcellular targeting
(17, 18). Rather, the distinct lipid modifications of each kinase
played an important role in both these phenotypes and in lo-
calization dynamics. Stimulation of polarized movement required
activation-dependent translocation of Src from a perinuclear
compartment to the plasma membrane. A prevailing hypothesis
regarding Src’s induction of polarization, derived from studies of
Src activation by integrins and growth factor receptors, is that Src
is activated at specific regions of the plasma membrane to pro-
duced localized protrusions and thereby drive polarized move-
ment (3, 45, 46). However, our observations suggest that
polarized migration can be initiated by activation of Src at
a perinuclear compartment. This raises two possibilities: either
activated Src is translocated to specific locations at the plasma
membrane, where it produces protrusion and migration, or Src
phosphorylates proteins in the perinuclear compartment, and
these proteins are then transported to locations at the cell
periphery. We were unable to identify any asymmetry of RapR
Src localization when it moved to the plasma membrane. Fur-
thermore, our data indicated that activated Src translocated to
the plasma membrane independently of MT, but Src-mediated
polarization of cells required an intact MT network. Thus, it
is most likely that MT are responsible for targeted delivery of
Src substrates that are initially phosphorylated by Src at the
perinuclear compartment.
This hypothesis is also consistent with our results showing that
RapR Src can stimulate polarized cell migration even when its
N-terminal portion has been substituted with the N-terminal
SH4-Unique domain of Fyn. This modification reduces the
perinuclear localization of inactive RapR Src normally seen
before activation, but a noticeable fraction still remains at the
perinuclear region. The reduced amount of RapR Src is appar-
ently still sufficient to phosphorylate the substrates in the peri-
nuclear compartment, and thereby induce polarized migration.
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Fig. 3. Modifying the N terminus of Src and Fyn
resulted in different cellular distributions and
translocations, with corresponding changes in ki-
nase-induced morphodynamics. (A) Nomenclature
of Fyn and Src constructs used in this study. Changes
in amino acids and protein domains are labeled in
red. (B) Kinase distribution was quantified as the
ratio of fluorescence intensities in a region of 10 μm
from the nucleus and in the remainder of the cell.
Error bars indicate 90% confidence intervals (n > 55
cells). Kinases were activated at time 0. The rela-
tively high initial values and decreasing ratio over
time indicated that Fyn Palm−, Src, and Src Palm+
were initially localized at the perinuclear region
and dispersed upon activation. The cellular distri-
bution of Fyn and Src(FynSH4U) was more diffuse
both before and after activation. (C) Representative
fluorescent images of COS-7 cells expressing Fyn,
Src, and their derivatives show the subcellular lo-
calization of kinases before and after activation, as
cells undergo morphological changes. Arrows in-
dicate direction of movement.
























However, the reduced levels of perinuclear Src led to delays in
the migratory response (Fig. 4C).
Simply changing the N-terminal lipidation of Fyn to that of Src
was sufficient to localize Fyn to the perinuclear compartment, and
also enabled Fyn to generate the Src-specific phenotype. This,
together with the fact that SH2 and SH3 substitutions had little
effect on the differences between Fyn and Src, suggests that
localization controls the substrate interactions and/or substrate
interaction kinetics that produce differences between Src
and Fyn.
In summary, rapid activation of the kinases made it possible
to follow transient events they induced. In contrast, genetic
manipulations generate changes over hours, altering protein
expression rather than activation, and produce changes with
widely differing rates across cell populations (Fig. S8).
Although several studies have reported differences in the
localization and trafficking of individual SFKs, this study
presents direct evidence that distinct localizations of SFK are
responsible for inducing different cellular responses, and sheds
light on the role of trafficking in induction of polarization by Src.
Because the site of iFKBP insertion in RapR kinases is highly
conserved (19, 20, 23), the approach can likely be used to dissect
the role of many kinases. Recent extensions include combining
iFKBP and FRB into a single insertable domain, and directing
the activated kinase to interact with a single, specific substrate
(22, 23).
Materials and Methods
Generation of Src- and Fyn-Derived RapR Kinases. The Fyn Palm+ (C3SC6S
mutant Fyn) and Src Palm− (S3CS6C mutant Src) constructs were generated
using the modified site-directed mutagenesis method described in SI
Materials and Methods. The Src(FynSH4U) was prepared by replacing the
SH4 and Unique domains of Src (aa 1–82) with those of Fyn (aa 1–81). To
generate Src(FynSH32) and Fyn(SrcSH32), overlap extension PCR was used
to generate the SrcSH3SH2 domain (Gly83 to Cys253) or the FynSH3SH2
domain (Thr82 to Cys246) and these were inserted into the corresponding
site of RapR Fyn or RapR Src, to replace their original domains.
Live Cell Imaging. For cell morphology studies, COS-7 cells expressing EGFP-
tagged RapR kinases and mCherry-tagged FRB were used. Cells were plated
on fibronectin-coated coverslips (5 ug/mL fibronectin) 2 h before the ex-
periment, then transferred to L-15 medium (Invitrogen) supplemented with
5% (vol/vol) FBS. Rapamycin was added into themedium 30min after imaging.
Live cell imaging was performed in a heated chamber using an Olympus IX-81
microscope equipped with an UPlanFLN 40× objective (Oil, N.A. 1.30). Image
analysis was performed using Metamorph and MATLAB software. For focal
adhesion studies, COS-7 cells expressing CFP-tagged RapR kinase, mCherry-
tagged FRB, and mVenus-tagged vinculin were used. Live cell imaging was
performed using an Olympus IX-81 microscope equipped with an objective-
based total internal reflection fluorescence (TIRF) system and a PlanApo N 60×
TIRF objective (N.A. 1.45). Time-lapse movies were taken at 2-min time inter-
vals. All images were collected using a Photometrics CoolSnap ES CCD camera.
Quantification of Morphological Changes. All morphometric quantities were
computed from fluorescence intensities generated by imaging COS-7 cells
expressing EGFP-tagged RapR kinases. The analysis was performed using
custom software written inMATLAB and specifically designed for this project.
All software modules include a Graphical User Interface (GUI) for easy use.
Image analysis involves two steps. The first step is cell boundary detection
using the MovThresh module, which automatically determines an intensity
threshold for each time frame of the movie. The GUI also provides options





























































































































































Fig. 4. Morphological changes induced by kinase activation. Graphs show
the percentage of cells undergoing each behavior quantified as described in
Fig. 2 B and C. Rapamycin was added at time 0. The upper part of each graph
shows the percentage of cells that showed no response (black). P. Mv, P. Spr,
P. Shr, U. Shr, and U. Spr are defined as in Fig. 2D.






































































Fig. 5. Induction of polarized movement is dependent on translocation dy-
namics. (A) COS-7 cells treated with 10 μM nocodazole 30 min before Src ac-
tivation showed multiple protrusions extending with no clear polarization. (B)
Normalized mean kinase intensity at adhesions over time (shaded region
indicates 95% confidence interval). The vertical red line indicates time of rapa-
mycin treatment. (n > 15 cells from two independent experiments). (C) The
persistence of adhesions, plotted as the percent initial intensity of mVenus-
tagged vinculin remaining in adhesions over time (shaded regions show 95%
confidence intervals, intensity at time of rapamycin addition = 100%).
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that allow manual adjustment of the threshold value as needed. The second
step is motion classification using the Squigglymorph module. This module
finds and displays regions of protrusion and retraction using pairwise com-
parisons of cell boundary points at times t and t+T, where T is a user-defined
time lag. The distribution of protruding boundary points is visualized by
mapping the cell boundary to a circle, and boundary movements are












where a is the angular coordinate of the boundary point on the circle and
l(a) is the corresponding displacement of the boundary point between time t
and t+T. For the polarization index,
PðtÞ=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Æpx æ2 + Æpy æ2
q
,
we use a running average of three polarization vectors from consecutive time
points, which accounts for the persistence of the polarization. The polarization
index and the rate of area change, R(t) = dA/dt, form a phase space that divides
cell movement into six regions: (i) uniform spreading (P < Pcr, R > Rcr), (ii) po-
larized spreading (P ≥ Pcr, R > Rcr), (iii) uniform shrinkage (P < Pcr, R < ‒ Rcr), (iv)
polarized shrinkage (P ≥ Pcr, R < ‒ Rcr), (v) polarized movement (P ≥ Pcr, jRj ≤
Rcr), and (vi) steady state (P < Pcr, jRj ≤ Rcr). At each time point the cell is
characterized as being in one of the six possible modes of motion and the
dynamic behavior of the cell is visualized as a trajectory moves through phase
space. The parameters Pcr and Rcr were adjusted to achieve good correspon-
dence between the visually observed behavior and output from the analysis.
For the analyses presented here the values of Pcr and Rcr were taken to be 0.28
and 0.005, respectively. The analysis results for individual cells (n > 55 for each
construct) were then used to perform statistical analysis. Additional features of
Squigglymorph include: (i) construction of smoothed curves for the parameters
P(t) and R(t) using a user-defined smoothing window, and (ii) calculation of the
mean-squared displacement (MSD) of the centroids and fitting the resulting
curve to a persistent random walk to compute an estimate for the centroid








The directional persistence time P was obtained by MSD analysis of time-
lapse movies of over 180 min in length.
Antibodies and reagents, cell culture, immunoprecipitation and kinase
assays, cloning procedures, and focal adhesion imaging are described in SI
Materials and Methods.
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